Nutraceuticals as ligands of PPARγ

PPAR Research

Volumn , Issue , 2012, Pages

  Penumetcha, Meera ^a   Santanam, Nalini ^b  

^a Division of Nutrition   (United States)

^b MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

13 HYDROXYOCTADECADIENOIC ACID; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 4 HYDROXYDOCOSAHEXAENOIC ACID; 4 OXODOCOSAHEXAENOIC ACID; 9 HYDROXYOCTADECADIENOIC ACID; AZELAOYLPHOSPHATIDYLCHOLINE; BIOCHANIN A; CONJUGATED LINOLEIC ACID; DAIDZEIN; DOCOSAHEXAENOIC ACID; EQUOL; FLAVANOID; FLAVONOID; GENISTEIN; HESPERIDIN; ISOFLAVONE; ISOFLAVONE DERIVATIVE; LINOLEIC ACID; LIPID; NITROLINOLEIC ACID; NUTRACEUTICAL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLCHOLINE; PIOGLITAZONE; PSI BAPTIGENIN; QUERCETIN; ROSIGLITAZONE; ROSMARINIC ACID; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADIPOSE TISSUE; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG RESEARCH; FAT INTAKE; GLUCOSE METABOLISM; HIGH THROUGHPUT SCREENING; HUMAN; INSULIN METABOLISM; LIPID METABOLISM; LIPID STORAGE; LIVER; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; TISSUE DISTRIBUTION; UNSPECIFIED SIDE EFFECT;

EID: 84863675791     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/858352     Document Type: Review

References (75)

1. Tontonoz P., Spiegelman B. M., Fat and beyond: the diverse biology of PPAR Annual Review of Biochemistry 2008 77 289 312
2. Evans R. M., Barish G. D., Wang Y. X., PPARs and the complex journey to obesity Nature Medicine 2004 10 4 355 361 (Pubitemid 38508511)
3. Heikkinen S., Auwerx J., Argmann C. A., PPAR in human and mouse physiology Biochimica et Biophysica Acta 2007 1771 8 999 1013
4. Glass C. K., Saijo K., Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells Nature Reviews Immunology 2010 10 5 365 376
5. Stafylas P. C., Sarafidis P. A., Lasaridis A. N., The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality International Journal of Cardiology 2009 131 3 298 304
6. Kawai M., Rosen C. J., PPAR : a circadian transcription factor in adipogenesis and osteogenesis Nature Reviews Endocrinology 2010 6 11 629 636
7. Lehmann J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Willson T. M., Kliewer S. A., An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor (PPAR ) The Journal of Biological Chemistry 1995 270 22 12953 12956
8. Kliewer S. A., Umesono K., Noonan D. J., Heyman R. A., Evans R. M., Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 1992 358 6389 771 774
9. Kletzien R. F., Foellmi L. A., Harris P. K. W., Wyse B. M., Clarke S. D., Adipocyte fatty acid-binding protein: regulation of gene expression in vivo and in vitro by an insulin-sensitizing agent Molecular Pharmacology 1992 42 4 558 562 (Pubitemid 23027615)
10. Graves R. A., Tontonoz P., Spiegelman B. M., Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression Molecular and Cellular Biology 1992 12 3 1202 1208
11. Peraza M. A., Burdick A. D., Marin H. E., Gonzalez F. J., Peters J. M., The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR) Toxicological Sciences 2006 90 2 269 295
12. Pirat C., Farce A., Lebegue N., Targeting peroxisome proliferator- activated receptors (PPARs): development of modulators Journal of Medicinal Chemistry 2012 55 9 4027 4061
13. Dunn F. L., Higgins L. S., Fredrickson J., Depaoli A. M., Selective modulation of PPAR activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with type 2 diabetes Journal of Diabetes and its Complications 2011 25 3 151 158
14. Shearer B. G., Billin A. N., The next generation of PPAR drugs: do we have the tools to find them? Biochimica et Biophysica Acta 2007 1771 8 1082 1093 (Pubitemid 47202036)
15. Balint B. L., Nagy L., Selective modulators of PPAR activity as new therapeutic tools in metabolic diseases Endocrine, Metabolic and Immune Disorders 2006 6 1 33 43 (Pubitemid 43796712)
16. Feldman P. L., Lambert M. H., Henke B. R., PPAR modulators and PPAR pan agonists for metabolic diseases: the next generation of drugs targeting peroxisome proliferator-activated receptors? Current Topics in Medicinal Chemistry 2008 8 9 728 749 (Pubitemid 351982563)
17. Higgins L. S., Depaoli A. M., Selective peroxisome proliferator-activated receptor (PPAR ) modulation as a strategy for safer therapeutic PPAR activation American Journal of Clinical Nutrition 2010 91 1 267S 272S
18. Bruning J. B., Chalmers M. J., Prasad S., Busby S. A., Kamenecka T. M., He Y., Nettles K. W., Griffin P. R., Partial agonists activate PPAR using a helix 12 independent m echanism Structure 2007 15 10 1258 1271 (Pubitemid 47539157)
19. Huang T. H. W., Teoh A. W., Lin B. L., Lin D. S. H., Roufogalis B., The role of herbal PPAR modulators in the treatment of cardiometabolic syndrome Pharmacological Research 2009 60 3 195 206
20. de Silva A., Lanerolle P., Nutraceuticals: concepts and controversies Ceylon Medical Journal 2011 56 4 171 173
21. Zeisel S. H., Regulation of nutraceuticals Science 1999 285 5435 1853 1855
22. Schopfer F. J., Lin Y., Baker P. R. S., Cui T., Garcia-Barrio M., Zhang J., Chen K., Chen Y. E., Freeman B. A., Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor ligand Proceedings of the National Academy of Sciences of the United States of America 2005 102 7 2340 2345 (Pubitemid 40279377)
23. Alexander R. L., Wright M. W., Gorczynski M. J., Smitherman P. K., Akiyama T. E., Wood H. B., Berger J. P., King S. B., Morrow C. S., Differential potencies of naturally occurring regioisomers of nitrolinoleic acid in PPAR activation Biochemistry 2009 48 2 492 498
24. Davies S. S., Pontsler A. V., Marathe G. K., Harrison K. A., Murphy R. C., Hinshaw J. C., Prestwich G. D., Hilaire A. S., Prescott S. M., Zimmerman G. A., McIntyre T. M., Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor ligands and agonists The Journal of Biological Chemistry 2001 276 19 16015 16023
25. Itoh T., Yamamoto K., Peroxisome proliferator activated receptor and oxidized docosahexaenoic acids as new class of ligand Naunyn-Schmiedeberg's Archives of Pharmacology 2008 377 46 541 547
26. Belury M. A., Moya-Camarena S. Y., Lu M., Shi L., Leesnitzer L. M., Blanchard S. G., Conjugated linoleic acid is an activator and ligand for peroxisome proliferator-activated receptor-gamma (PPAR ) Nutrition Research 2002 22 7 817 824 (Pubitemid 34755661)
27. Dang Z. C., Audinot V., Papapoulos S. E., Boutin J. A., Lowik C. W. G. M., Peroxisome proliferator-activated receptor (PPAR ) as a molecular target for the soy phytoestrogen genistein The Journal of Biological Chemistry 2003 278 2 962 967 (Pubitemid 36790772)
28. Cho K. W., Lee O. H., Banz W. J., Moustaid-Moussa N., Shay N. F., Kim Y. C., Daidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPAR transcriptional activity Journal of Nutritional Biochemistry 2010 21 9 841 847
29. Shen P., Liu M. H., Ng T. Y., Chan Y. H., Yong E. L., Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPAR, PPAR, and adipocyte differentiation in vitro Journal of Nutrition 2006 136 4 899 905
30. Salam N. K., Huang T. H. W., Kota B. P., Kim M. S., Li Y., Hibbs D. E., Novel PPAR-gamma agonists identified from a natural product library: a virtual screening, induced-fit docking and biological assay study Chemical Biology and Drug Design 2008 71 1 57 70
31. Jungbauer A., Medjakovic S., Anti-inflammatory properties of culinary herbs and spices that ameliorate the effects of metabolic syndrome Maturitas 2012 71 3 227 239
32. Fei J., Cook C., Gillespie M., Yu B., Fullen K., Santanam N., Atherogenic omega-6 lipids modulate PPAR-EGR-1 crosstalk in vascular cells PPAR Research 2011 2011 11
33. Garelnabi M., Selvarajan K., Litvinov D., Santanam N., Parthasarathy S., Dietary oxidized linoleic acid lowers triglycerides via APOA5/APOClll dependent mechanisms Atherosclerosis 2008 199 2 304 309
34. Barlic J., Murphy P. M., An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion Trends in Cardiovascular Medicine 2007 17 8 269 274 (Pubitemid 350087697)
35. Kita T., Arai H., Oxidized fatty acid and PPAR-gamma Nippon Rinsho 2001 59 823 830
36. Siess W., Tigyi G., Thrombogenic and atherogenic activities of lysophosphatidic acid Journal of Cellular Biochemistry 2004 92 6 1086 1094 (Pubitemid 44264220)
37. Uchida K., Lipid peroxidation and redox-sensitive signaling pathways Current Atherosclerosis Reports 2007 9 3 216 221 (Pubitemid 47629069)
38. Wolf G., The role of oxidized low-density lipoprotein in the activation of peroxisome proliferator-activated receptor : implications for atherosclerosis Nutrition Reviews 1999 57 3 88 91 (Pubitemid 29176622)
39. Itoh T., Fairall L., Amin K., Inaba Y., Szanto A., Balint B. L., Nagy L., Yamamoto K., Schwabe J. W. R., Structural basis for the activation of PPAR by oxidized fatty acids Nature Structural and Molecular Biology 2008 15 9 924 931
40. Li Y., Zhang J., Schopfer F. J., Martynowski D., Garcia-Barrio M. T., Kovach A., Suino-Powell K., Baker P. R. S., Freeman B. A., Chen Y. E., Xu H. E., Molecular recognition of nitrated fatty acids by PPAR Nature Structural and Molecular Biology 2008 15 8 865 867
41. Waku T., Shiraki T., Oyama T., Fujimoto Y., Maebara K., Kamiya N., Jingami H., Morikawa K., Structural insight into PPAR activation through covalent modification with endogenous fatty acids Journal of Molecular Biology 2009 385 1 188 199
42. Yokoi H., Mizukami H., Nagatsu A., Tanabe H., Inoue M., Hydroxy monounsaturated fatty acids as agonists for peroxisome proliferator-activated receptors Biological and Pharmaceutical Bulletin 2010 33 5 854 861
43. Xu H. E., Lambert M. H., Montana V. G., Parks D. J., Blanchard S. G., Brown P. J., Sternbach D. D., Lehmann J. M., Wisely G. B., Willson T. M., Kliewer S. A., Milburn M. V., Molecular recognition of fatty acids by peroxisome proliferator-activated receptors Molecular Cell 1999 3 3 397 403 (Pubitemid 29290680)
44. Penumetcha M., Khan N., Parthasarathy S., Dietary oxidized fatty acids: an atherogenic risk? Journal of Lipid Research 2000 41 9 1473 1480
45. Staprans I., Hardman D. A., Pan X. M., Feingold K. R., Effect of oxidized lipids in the diet on oxidized lipid levels in postprandial serum chylomicrons of diabetic patients Diabetes Care 1999 22 2 300 306 (Pubitemid 29056926)
46. Staprans I., Pan X. M., Rapp J. H., Feingold K. R., Oxidized cholesterol in the diet is a source of oxidized lipoproteins in human serum Journal of Lipid Research 2003 44 4 705 715 (Pubitemid 37279672)
47. Ringseis R., Piwek N., Eder K., Oxidized fat induces oxidative stress but has no effect on NF- B-mediated proinflammatory gene transcription in porcine intestinal epithelial cells Inflammation Research 2007 56 3 118 125 (Pubitemid 46570794)
48. Moya-Camarena S. Y., Vanden Heuvel J. P., Blanchard S. G., Leesnitzer L. A., Belury M. A., Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPAR Journal of Lipid Research 1999 40 8 1426 1433 (Pubitemid 29379982)
49. Bassaganya-Riera J., Hontecillas R., Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease Current Opinion in Clinical Nutrition and Metabolic Care 2010 13 5 569 573
50. Limor R., Sharon O., Knoll E., Many A., Weisinger G., Stern N., Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor -2 expression in human vascular smooth muscle cells American Journal of Hypertension 2008 21 2 219 223 (Pubitemid 351231570)
51. Huang J. T., Welch J. S., Ricote M., Binder C. J., Willson T. M., Kelly C., Witztum J. L., Funk C. D., Conrad D., Glass C. K., Interleukin-4-dependent production of PPAR- ligands in macrophages by 12/15-lipoxygenase Nature 1999 400 6742 378 382 (Pubitemid 29344205)
52. Nagy L., Tontonoz P., Alvarez J. G. A., Chen H., Evans R. M., Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR Cell 1998 93 2 229 240 (Pubitemid 28180856)
53. Forman B. M., Chen J., Evans R. M., Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors and Proceedings of the National Academy of Sciences of the United States of America 1997 94 9 4312 4317 (Pubitemid 27194238)
54. Medjakovic S., Mueller M., Jungbauer A., Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR Nutrients 2010 2 3 241 279
55. Chacko B. K., Chandler R. T., D'Alessandro T. L., Mundhekar A., Khoo N. K. H., Botting N., Barnes S., Patel R. P., Anti-inflammatory effects of isoflavones are dependent on flow and human endothelial cell PPAR Journal of Nutrition 2007 137 2 351 356 (Pubitemid 46213448)
56. Phrakonkham P., Viengchareun S., Belloir C., Lombes M., Artur Y., Canivenc-Lavier M. C., Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis Journal of Steroid Biochemistry and Molecular Biology 2008 110 1-2 95 103
57. Park H. J., Della-Fera M. A., Hausman D. B., Rayalam S., Ambati S., Baile C. A., Genistein inhibits differentiation of primary human adipocytes Journal of Nutritional Biochemistry 2009 20 2 140 148
58. Penza M., Montani C., Romani A., Vignolini P., Pampaloni B., Tanini A., Brandi M. L., Alonso-Magdalena P., Nadal A., Ottobrini L., Parolini O., Bignotti E., Calza S., Maggi A., Grigolato P. G., Di Lorenzo D., Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner Endocrinology 2006 147 12 5740 5751 (Pubitemid 44833490)
59. Naaz A., Yellayi S., Zakroczymski M. A., Bunick D., Doerge D. R., Lubahn D. B., Helferich W. G., Cooke P. S., The soy isoflavone genistein decreases adipose deposition in mice Endocrinology 2003 144 8 3315 3320 (Pubitemid 36904405)
60. Zhang F., Lavan B. E., Gregoire F. M., Selective modulators of PPAR- activity: molecular aspects related to obesity and side-effects PPAR Research 2007 2007
61. Kim H. K., Nelson-Dooley C., Della-Fera M. A., Yang J. Y., Zhang W., Duan J., Hartzell D. L., Hamrick M. W., Baile C. A., Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice Journal of Nutrition 2006 136 2 409 414 (Pubitemid 43228294)
62. Maul R., Kulling S. E., Absorption of red clover isoflavones in human subjects: results from a pilot study British Journal of Nutrition 2010 103 11 1569 1572
63. Lee M. S., Kim C. T., Kim Y., Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice Annals of Nutrition and Metabolism 2009 54 2 151 157
64. Chan C. Y., Wei L., Castro-Munozledo F., Koo W. L., (-)-Epigallocatechin- 3-gallate blocks 3T3-L1 adipose conversion by inhibition of cell proliferation and suppression of adipose phenotype expression Life Sciences 2011 89 21-22 779 785
65. Egert S., Rimbach G., Which sources of flavonoids: complex diets or dietary supplements? Advances in Nutrition 2011 2 1 8 14
66. Kyselova Z., Toxicological aspects of the use of phenolic compounds in disease prevention Interdisciplinary Toxicology 2011 4 4 173 183
67. Hooper L., Summerbell C. D., Thompson R., Sills D., Roberts F. G., Moore H., Davey Smith G., Reduced or modified dietary fat for preventing cardiovascular disease Cochrane Database of Systematic Reviews 2011 7
68. Salas-Salvado J., Martinez-Gonzalez M. A., Bullo M., Ros E., The role of diet in the prevention of type 2 diabetes Nutrition, Metabolism and Cardiovascular Diseases 2011 21 supplement 2 B32 B48
69. Choi E. J., Kim T., Daidzein modulates induction of hepatic CYP1A1, 1B1, and AhR by 7,12-dimethylbenz[a]anthracene in mice Archives of Pharmacal Research 2008 31 9 1115 1119
70. Simmen F. A., Mercado C. P., Zavacki A. M., Huang S. A., Greenway A. D., Kang P., Bowman M. T., Prior R. L., Soy protein diet alters expression of hepatic genes regulating fatty acid and thyroid hormone metabolism in the male rat Journal of Nutritional Biochemistry 2010 21 11 1106 1113
71. Cermak R., Effect of dietary flavonoids on pathways involved in drug metabolism Expert Opinion on Drug Metabolism and Toxicology 2008 4 1 17 35 (Pubitemid 351234098)
72. Govindarajan R., Ratnasinghe L., Simmons D. L., Siegel E. R., Midathada M. V., Kim L., Kim P. J., Owens R. J., Lang N. P., Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes Journal of Clinical Oncology 2007 25 12 1476 1481 (Pubitemid 46733074)
73. Koro C., Barrett S., Qizilbash N., Cancer risks in thiazolidinedione users compared to other anti-diabetic agents Pharmacoepidemiology and Drug Safety 2007 16 5 485 492 (Pubitemid 46824269)
74. Ramos-Nino M. E., MacLean C. D., Littenberg B., Association between cancer prevalence and use of thiazolidinediones: results from the Vermont diabetes information system BMC Medicine 2007 5, article 17
75. Andres S., Abraham K., Appel K. E., Lampen A., Risks and benefits of dietary isoflavones for cancer Critical Reviews in Toxicology 2011 41 6 463 506